UF Innovate | Incubation Services Resident Signum Biosciences Launches Epicutis, a Professional Luxury Medical-Grade Skincare Line
UF Innovate | Sid Martin Biotech resident Signum Biosciences, a biopharma company with 20 years of topical drug development and skincare ingredient expertise, announced the launch of Epicutis, a new professional, medical-grade luxury skincare line. Honoring a commitment to clean beauty and fewer ingredients, Epicutis offers science-based skincare that treats skin health with small-batch formulations and complete transparency.
For decades, Signum Biosciences has been an ingredient supplier to the cosmetic industry. During this time, Signum developed relationships with companies in one of the most technologically advanced cosmetics markets in the world, Japan. To bring Japanese knowledge to clean beauty products in the United States, Stock began working with expert scientist and formulator Masanori Tamura, who has over ten years of formulation experience in Japan, to develop Epicutis. Utilizing technology discovered by Dr. Jeffry Stock, Professor of Molecular Biology at Princeton University, Epicutis products are formulated exclusively with non-toxic, high quality, patented active ingredients with the goal of attaining and maintaining healthy skin, from the inside out. With highly concentrated therapeutic ingredients that are sourced with transparency from in-house manufacturers, Epicutis differentiates itself from most skincare products by removing the mystery behind what we put on our skin.
Learn more about UF Innovate | Incubation Services Resident Signum Biosciences Launches Epicutis, a Professional Luxury Medical-Grade Skincare Line.